Erhard Trillingsgaard Næss-Schmidt

Erhard Trillingsgaard Næss-Schmidt

Auto-generated profile, based on publicly available information

Erhard Trillingsgaard Næss-Schmidt

Hammel Neurorehabilitation Centre and University Research Clinic, Aarhus University, Hammel, Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2013 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
LØLeif Østergaard
Leif Østergaard
RARasmus Aamand
Rasmus Aamand
SKSanja Karabegovic
Sanja Karabegovic
ATAnna Tietze
Anna Tietze
JBJakob Udby Blicher
Jakob Udby Blicher
JSJens Christian Hedemann Sørensen
Jens Christian Hedemann Sørensen
The mortality after aneurysmal subarachnoid hemorrhage (SAH) is 50%, and most survivors suffer severe functional and cognitive deficits. Half of SAH patients deteriorate 5 to 14 days after the initial bleeding, so-called delayed cerebral ischemia (DCI). Although often attributed to vasospasms, DCI may develop in the absence of angiographic vasospasms, and therapeutic reversal of angiographic vasospasms fails to improve patient outcome. The etiology of chronic neurodegenerative changes after SAH remains poorly understood. Brain oxygenation depends on both cerebral blood flow (CBF) and its microscopic distribution, the so-called capillary transit time heterogeneity (CTH). In theory, increased CTH can therefore lead to tissue hypoxia in the absence of severe CBF reductions, whereas reductions in CBF, paradoxically, improve brain oxygenation if CTH is critically elevated. We review potential sources of elevated CTH after SAH. Pericyte constrictions in relation to the initial ischemic episode and subsequent oxidative stress, nitric oxide depletion during the pericapillary clearance of oxyhemoglobin, vasogenic edema, leukocytosis, and astrocytic endfeet swelling are identified as potential sources of elevated CTH, and hence of metabolic derangement, after SAH. Irreversible changes in capillary morphology and function are predicted to contribute to long-term relative tissue hypoxia, inflammation, and neurodegeneration. We discuss diagnostic and therapeutic implications of these predictions.

23 July 2014 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
LØLeif Østergaard
Leif Østergaard
TEThorbjørn S Engedal
Thorbjørn S Engedal
RARasmus Aamand
Rasmus Aamand
RMRonni Mikkelsen
Ronni Mikkelsen
NINina K Iversen
Nina K Iversen
MRMads Rasmussen
Mads Rasmussen
Most patients who die after traumatic brain injury (TBI) show evidence of ischemic brain damage. Nevertheless, it has proven difficult to demonstrate cerebral ischemia in TBI patients. After TBI, both global and localized changes in cerebral blood flow (CBF) are observed, depending on the extent of diffuse brain swelling and the size and location of contusions and hematoma. These changes vary considerably over time, with most TBI patients showing reduced CBF during the first 12hours after injury, then hyperperfusion, and in some patients vasospasms before CBF eventually normalizes. This apparent neurovascular uncoupling has been ascribed to mitochondrial dysfunction, hindered oxygen diffusion into tissue, or microthrombosis. Capillary compression by astrocytic endfeet swelling is observed in biopsies acquired from TBI patients. In animal models, elevated intracranial pressure compresses capillaries, causing redistribution of capillary flows into patterns argued to cause functional shunting of oxygenated blood through the capillary bed. We used a biophysical model of oxygen transport in tissue to examine how capillary flow disturbances may contribute to the profound changes in CBF after TBI. The analysis suggests that elevated capillary transit time heterogeneity can cause critical reductions in oxygen availability in the absence of ‘classic’ ischemia. We discuss diagnostic and therapeutic consequences of these predictions.

22 July 2014 in Neurorehabilitation and Neural Repair
Verified
Journal Article
Open access
PDF file
JBJakob Udby Blicher
Jakob Udby Blicher
JNJamie Near
Jamie Near
ENErhard Næss-Schmidt
Erhard Næss-Schmidt
CSCharlotte J. Stagg
Charlotte J. Stagg
HJHeidi Johansen-Berg
Heidi Johansen-Berg
YHYi-Ching Lynn Ho
Yi-Ching Lynn Ho
Background and Objective. γ-Aminobutyric acid (GABA) is the dominant inhibitory neurotransmitter in the brain and is important in motor learning. We aimed to measure GABA content in primary motor cortex poststroke (using GABA-edited magnetic resonance spectroscopy [MRS]) and in relation to motor recovery during 2 weeks of constraint-induced movement therapy (CIMT). Methods. Twenty-one patients (3-12 months poststroke) and 20 healthy subjects were recruited. Magnetic resonance imaging structural T1 and GABA-edited MRS were performed at baseline and after CIMT, and once in healthy subjects. GABA:creatine (GABA:Cr) ratio was measured by GABA-edited MRS. Motor function was measured using Wolf Motor Function Test (WMFT). Results. Baseline comparison between stroke patients (n = 19) and healthy subjects showed a significantly lower GABA:Cr ratio in stroke patients (P < .001) even after correcting for gray matter content in the voxel (P < .01) and when expressing GABA relative to N-acetylaspartic acid (NAA; P = .03). After 2 weeks of CIMT patients improved significantly on WMFT, but no consistent change across the group was observed for the GABA:Cr ratio (n = 17). However, the extent of improvement on WMFT correlated significantly with the magnitude of GABA:Cr changes (P < .01), with decreases in GABA:Cr ratio being associated with better improvements in motor function. Conclusions. In patients 3 to 12 months poststroke, GABA levels are lower in the primary motor cortex than in healthy subjects. The observed association between GABA and recovery warrants further studies on the potential use of GABA MRS as a biomarker in poststroke recovery.

20 June 2016 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Open access
PDF file
ENErhard Næss-Schmidt
Erhard Næss-Schmidt
ATAnna Tietze
Anna Tietze
JBJakob Udby Blicher
Jakob Udby Blicher
MPMikkel Petersen
Mikkel Petersen
IMIrene K Mikkelsen
Irene K Mikkelsen
SESimon Eskildsen
Simon Eskildsen
Purpose In both structural and functional MRI, there is a need for accurate and reliable automatic segmentation of brain regions. Inconsistent segmentation reduces sensitivity and may bias results in clinical studies. The current study compares the performance of publicly available segmentation tools and their impact on diffusion quantification, emphasizing the importance of using recently developed segmentation algorithms and imaging techniques. Methods Four publicly available, automatic segmentation methods (volBrain, FSL, FreeSurfer and SPM) are compared to manual segmentation of the thalamus and hippocampus imaged with a recently proposed T1-weighted MRI sequence (MP2RAGE). We evaluate morphometric accuracy on 22 healthy subjects and impact on diffusivity measurements obtained from aligned diffusion-weighted images on a subset of 10 subjects. Results Compared to manual segmentation, the highest Dice similarity index of the thalamus is obtained with volBrain using a local library (\(M=0.913\), \(\hbox {SD}=0.014\)) followed by volBrain using an external library (\(M=0.868\), \(\hbox {SD}=0.024\)), FSL (\({M}=0.806\), \(\mathrm{SD}=0.034\)), FreeSurfer (\({M}=0.798\), \(\mathrm{SD}=0.049\)) and SPM (\({M}=0.787\), \(\mathrm{SD}=0.031\)). The same order is found for hippocampus with volBrain local (\({M}=0.892\), \(\mathrm{SD}=0.016\)), volBrain external (\({M}=0.859\), \(\mathrm{SD}=0.014\)), FSL (\({M}=0.808\), \(\mathrm{SD}=0.017\)), FreeSurfer (\({M}=0.771\), \(\mathrm{SD}=0.023\)) and SPM (\({M}=0.735\), \(\mathrm{SD}=0.038\)). For diffusivity measurements, volBrain provides values closest to those obtained from manual segmentations. volBrain is the only method where FA values do not differ significantly from manual segmentation of the thalamus. Conclusions Overall we find that volBrain is superior in thalamus and hippocampus segmentation compared to FSL, FreeSurfer and SPM. Furthermore, the choice of segmentation technique and training library affects quantitative results from diffusivity measures in thalamus and hippocampus.

1 December 2019 in eClinicalMedicine
Verified
Journal Article
Open access
MTMille Moeller Thastum
Mille Moeller Thastum
CRCharlotte Ulrikka Rask
Charlotte Ulrikka Rask
ENErhard Trillingsgaard Næss-Schmidt
Erhard Trillingsgaard Næss-Schmidt
ATAstrid Tuborgh
Astrid Tuborgh
JJJens Sondergaard Jensen
Jens Sondergaard Jensen
ASAndreas Schröder
Andreas Schröder
Evidence for effective interventions to prevent long-term sequelae after concussion is sparse. This study aimed to test the efficacy of Get going After concussIoN (GAIN), an interdisciplinary, individually-tailored intervention of 8 weeks duration based on gradual return to activities and principles from cognitive behavioural therapy. We conducted an open-label, parallel-group randomised trial in a hospital setting in Central Denmark Region. Participants were 15-30-year-old patients with high levels of post-concussion symptoms (PCS) 2-6 months post-concussion (i.e., a score ≥20 on the Rivermead Post-concussion Symptoms Questionnaire (RPQ)). They were randomly assigned (1:1) to either enhanced usual care (EUC) or GAIN+EUC. Masking of participants and therapists was not possible. The primary outcome was change in RPQ-score from baseline to 3-month FU. All analyses were done on an intention-to-treat basis using linear mixed-effects models. This trial is registered with ClinicalTrials.gov, number NCT02337101. Between March 1, 2015, and September 1, 2017, we included 112 patients. Patients allocated to GAIN+EUC (n=57) reported a significantly larger reduction of PCS than patients allocated to EUC (n=55) with a mean adjusted difference in improvement of 7·6 points (95% confidence interval (CI) 2·0-13·1, p=0·008), Cohen's d=0·5 (95% CI 0·1-0·9). Number needed to treat for prevention of one additional patient with RPQ ≥20 at 3-month FU was 3·6 (95% CI 2·2-11·3). No adverse events were observed. Compared with EUC, GAIN+EUC was associated with a larger reduction of post-concussion symptoms at 3-month FU. Central Denmark Region and the foundation "Public Health in Central Denmark Region - a collaboration between municipalities and the region".

5 January 2017 in Brain Injury
Verified
Journal Article
Closed access
ENErhard Trillingsgaard Næss-Schmidt
Erhard Trillingsgaard Næss-Schmidt
JBJakob Udby Blicher
Jakob Udby Blicher
SESimon Eskildsen
Simon Eskildsen
ATAnna Tietze
Anna Tietze
BHBrian Hansen
Brian Hansen
JNJørgen Feldbæk Nielsen
Jørgen Feldbæk Nielsen
Primary objective: The primary aim of this study was to assess microstructural changes in the thalamus, hippocampus and corpus callosum with a fast mean kurtosis tensor (MKT) technique, in the acute and sub-acute phase after mTBI. It was hypothesized that MKT would differ between baseline and follow-up in patients. The secondary aim was to relate diffusion measures to symptoms of mTBI. Research design: A longitudinal case-control study. Methods and procedures: Twenty-seven patients with mTBI and 27 age- and gender-matched healthy controls were enrolled in the study. Patients were scanned within 2 weeks and 3 months after mTBI, while the controls were scanned once. Main outcomes and results: MKT decreased significantly (p = 0.02) from baseline to follow-up in the thalamus in patients. Compared to healthy subjects, thalamic MKT values were significantly larger in patients at baseline (p = 0.048). Secondary analysis revealed a significant decrease (p = 0.01) in fractional anisotropy in the splenium of corpus callosum from baseline to follow-up. Conclusions: The current study indicates microstructural changes in the thalamus and corpus callosum from within 14 days to 3 months after mTBI and suggests MKT as a potential biomarker after mTBI.